Pleckstrin homology domain of phospholipase D2 is a negative regulator of focal adhesion kinase

BMB Rep. 2021 Feb;54(2):112-117. doi: 10.5483/BMBRep.2021.54.2.154.

Abstract

Phospholipase D2 (PLD2) has been implicated in the tyrosine kinase-mediated signaling pathways, but the regulation events are yet to be identified. Herein, we demonstrate that pleckstrin homology (PH) domain of PLD2 (PLD2-PH) exerts an antitumorigenic effect via the suppression of PLD2 and focal adhesion kinase (FAK). The kinase domain of FAK interacts with PLD2-PH and induces tyrosine phosphorylation and activation of PLD2. Furthermore, PLD2 increased tyrosine phosphorylation of FAK. However, ectopic expression of the PLD2-PH competes for binding to FAK and reduces the interaction between PLD2 and FAK, thereby suppressing FAK-induced PLD activation and tyrosine phosphorylation of FAK. The PLD2-PH suppressed the migration and invasion of glioblastoma cells, as well as tumor formation in a xenograft mouse model. This study uncovers a novel role of PLD2-PH as a negative regulator of PLD2 and FAK. [BMB Reports 2021; 54(2): 112-117].

Publication types

  • News

MeSH terms

  • Animals
  • Cell Line
  • Focal Adhesion Protein-Tyrosine Kinases / metabolism*
  • Humans
  • Phospholipase D / metabolism*
  • Pleckstrin Homology Domains
  • Rats

Substances

  • Focal Adhesion Protein-Tyrosine Kinases
  • phospholipase D2
  • Phospholipase D